FRANZINI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 6.547
EU - Europa 5.491
AS - Asia 3.392
SA - Sud America 958
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 16.489
Nazione #
US - Stati Uniti d'America 6.207
GB - Regno Unito 1.478
SG - Singapore 1.280
RU - Federazione Russa 1.234
IT - Italia 929
CN - Cina 917
BR - Brasile 793
VN - Vietnam 580
UA - Ucraina 485
PL - Polonia 353
DE - Germania 343
CA - Canada 268
HK - Hong Kong 226
DK - Danimarca 151
SE - Svezia 108
FI - Finlandia 99
FR - Francia 91
IE - Irlanda 83
AR - Argentina 64
IN - India 56
MX - Messico 55
KR - Corea 45
ID - Indonesia 44
BD - Bangladesh 40
NL - Olanda 40
JP - Giappone 36
EC - Ecuador 34
TR - Turchia 34
ZA - Sudafrica 32
IL - Israele 31
IQ - Iraq 26
ES - Italia 21
EU - Europa 16
AT - Austria 15
CO - Colombia 14
LT - Lituania 14
MA - Marocco 14
VE - Venezuela 13
UZ - Uzbekistan 12
PK - Pakistan 11
PY - Paraguay 11
CH - Svizzera 10
CL - Cile 10
EG - Egitto 10
PE - Perù 10
RO - Romania 10
SK - Slovacchia (Repubblica Slovacca) 9
AE - Emirati Arabi Uniti 7
SA - Arabia Saudita 7
TW - Taiwan 7
KE - Kenya 6
BE - Belgio 5
MY - Malesia 5
BO - Bolivia 4
JO - Giordania 4
NI - Nicaragua 4
SN - Senegal 4
UY - Uruguay 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
IR - Iran 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HN - Honduras 2
MM - Myanmar 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
ML - Mali 1
NC - Nuova Caledonia 1
NP - Nepal 1
PA - Panama 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
Totale 16.487
Città #
Dallas 1.339
Southend 1.186
Singapore 699
Beijing 460
Chandler 412
Ashburn 372
Warsaw 349
San Mateo 287
Pisa 242
Fairfield 240
Woodbridge 235
Jacksonville 227
Hong Kong 209
Ann Arbor 208
Moscow 208
Houston 188
Cambridge 162
Wilmington 160
Seattle 143
Dong Ket 140
Dearborn 129
Falls Church 126
Ho Chi Minh City 121
Boardman 114
Los Angeles 113
The Dalles 110
Hefei 92
Stevenage 92
Beauharnois 86
New York 83
Portsmouth 81
Dublin 78
Hanoi 75
Ottawa 75
São Paulo 75
Lawrence 74
Milan 68
Brooklyn 44
Buffalo 44
Montréal 40
Munich 39
Santa Clara 39
Montreal 34
Council Bluffs 33
Tokyo 33
Seoul 32
London 31
Rome 29
Chicago 28
Tel Aviv 27
Rio de Janeiro 24
San Diego 24
Johannesburg 23
Denver 21
Bologna 20
Da Nang 20
Redwood City 20
Boston 19
Brasília 19
Kansas City 18
Florence 17
San Francisco 17
Stockholm 17
Chennai 16
Mexico City 15
Poplar 15
Haiphong 14
Old Bridge 14
Ankara 13
Atlanta 13
Potenza 13
Biên Hòa 12
Norwalk 12
Orem 12
Pavia 12
Phoenix 12
Porto Alegre 12
Querétaro 12
Quito 12
Redondo Beach 12
Tashkent 12
Toronto 12
Turin 12
Amsterdam 11
Frankfurt am Main 11
Helsinki 11
Jakarta 11
Manchester 11
Nuremberg 11
Turku 11
Belo Horizonte 10
Fremont 10
Guayaquil 10
Istanbul 10
Shanghai 10
Baghdad 9
Bratislava 9
Campinas 9
Curitiba 9
Lima 9
Totale 10.199
Nome #
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 349
A High Performance Gel Filtration Chromatography Method for gamma-Glutamyltransferase Fraction Analysis 347
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 332
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 300
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 297
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 295
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 291
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 291
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 283
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 265
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 264
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 261
Gamma-glutammiltransferasi (GGT): biochimica clinica e patologia umana (Rassegna) 255
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 251
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 249
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 247
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 247
Marcatori di rimodellamento e fibrosi cardiaca 243
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. 235
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. 232
Circulating gamma-glutamyltransferase fractions in cirrhosis. 228
Indici di laboratorio di stress ossidativo. 223
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 219
Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells? 219
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 218
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 214
A novel marker of progression for atherosclerosis and cardiovascular diseases: serum gamma-glutamyltransferase enzyme activity. 211
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 211
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 211
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 209
Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration. 203
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 188
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 185
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials 184
State of the Art of Immunoassay Methods for B-Type Natriuretic Peptides: an Update 182
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values. 182
Valutazione di un metodo di dosaggio del BNP nel sangue capillare 180
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases. 179
Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. 178
State of the art of aldosterone immunoassays. 178
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? 177
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 175
Valutazione delle prestazioni analitiche del nuovo metodo per il dosaggio dell’aldosterone che utilizza la piattaforma LIAISON: confronto con altri metodi immunometrcici e con la psettrometria di massa 172
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study. 171
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 170
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 167
Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. 165
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 163
gamma-Glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. 161
Gamma-glutamyltransferase, H(2)O(2)-induced apoptosis and expression of catalase. 161
Stato dell’arte del dosaggio dei peptidi BNP e NT-proBNP: il controllo di qualità esterno CardioOrmoCheck 161
RNA-targeting and gene editing therapies for transthyretin amyloidosis 160
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained 159
PROCESS FOR DETERMINING S-NITROSOTHIOLS IN BIOLOGICALFLUIDS 158
Gamma-glutamyltransferase fractions in human plasma and bile: Characteristic and biogenesis 157
gamma-glutamiltransferasi e stress ossidativo. 154
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi 154
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 153
Cystic fibrosis, elevated gamma-glutamyltransferase, and lung transplant outcome. 153
Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections 152
The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. 150
Pathophysiology of Cardiac Amyloidosis 149
Serum gamma-glutamyltransferase fractions in Myotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease. 149
Vitamin C supply to bronchial epithelial cells linked to glutathione availability in elf - A role for secreted gamma-glutamyltransferase. 147
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians. 147
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 146
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 145
Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. 142
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 139
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 139
Gamma-glutamyltransferases: exploring the complexity of a multifunctional family of enzymes 137
Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. 137
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 135
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 134
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 134
Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting 134
Use of biomarkers to diagnose and manage cardiac amyloidosis 132
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. 130
Plasma gamma-glutamyltransferase (GGT) activity in inflammatory bowel disease: is the clinical laboratory plasma GGT assay sensitive enough for gastroenterology? 129
Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. 126
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. 125
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 117
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 108
Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos 107
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 102
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 94
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 92
Totale 16.555
Categoria #
all - tutte 84.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.107 0 0 0 0 0 162 181 83 109 101 147 324
2021/20221.122 88 222 40 77 27 28 128 219 66 132 18 77
2022/2023965 80 31 26 163 142 177 19 74 178 15 41 19
2023/2024543 50 24 76 27 17 74 47 44 19 21 48 96
2024/20253.229 46 36 148 77 121 199 506 964 234 143 513 242
2025/20265.430 412 1.523 1.006 1.172 833 484 0 0 0 0 0 0
Totale 16.555